Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ATP-sensitive potassium channel (KATP) in arterial smooth muscle is a hetero-octameric ion channel composed of Kir6.x and SURx subunits. It couples cellular metabolism to membrane potential and vascular tone. Activation leads to vasodilation, while inhibition promotes vasoconstriction. It is implicated in cardiovascular diseases such as hypertension and diabetes-related vascular dysfunction.
Activation leads to vasodilation by hyperpolarizing the cell membrane; inhibition leads to vasoconstriction by depolarizing the cell membrane
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-sensitive potassium channel (KATP) in arterial smooth muscle (KATP).